Neoadjuvant endocrine therapy for breast cancer: past, present and future-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neoadjuvant endocrine therapy for breast cancer: past, present and future

Published:2008-04 Issue:4 Volume:19 Page:339-347
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Barnadas Agustí,Gil Miguel,Sánchez-Rovira Pedro,Llombart Antonio,Adrover Encarna,Estevez Laura G.,de la Haba Juan,Calvo Lourdes

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference70 articles.

1. On the treatment of inoperable cases of carcinoma of the mamma: suggestion for a new method of treatment, with illustrative cases;Beatson;Lancet,1896

2. Tamoxifen (antiestrogen) therapy in advanced breast cancer;Kiang;Ann Intern Med,1977

3. Tamoxifen. Use in treatment of metastatic breast cancer refractory to combination chemotherapy;Legha;JAMA,1979

4. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Lancet,2005

5. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study;Fisher;J Natl Cancer Inst,2005

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefit of the addition of hormone therapy to neoadjuvant anthracycline-based chemotherapy for breast cancer: comparison of predicted and observed pCR;Journal of Cancer Research and Clinical Oncology;2018-01-17

2. Neoadjuvant and Adjuvant Therapies for Breast Cancer;Southern Medical Journal;2017-10

3. Feasibility, accuracy and prognosis of sentinel lymph node biopsy before neoadjuvant therapy in breast cancer. A prospective study;International Journal of Surgery;2017-03

4. Alterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cells;PLOS ONE;2017-02-14

5. Novel Translational Research of Neo-adjuvant Endocrine Therapy;Personalized Treatment of Breast Cancer;2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3